
Calix, Inc.
CALXNYSETechnology● Active
$37.80
+$0.53(+1.41%)
Market Cap$2.4B
P/E Ratio—
52W High$71.22
52W Low$37.26
Calix, Inc.(CALX)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CALX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.00B | $0.83B | $1.04B | $0.87B | $0.68B |
| Cost of Revenue | $0.43B | $0.38B | $0.52B | $0.43B | $0.32B |
| Gross Profit | $0.57B | $0.45B | $0.52B | $0.44B | $0.36B |
| Gross Margin %(computed) | 56.83% | 54.55% | 49.86% | 50.17% | 52.49% |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.18B | $0.18B | $0.13B | $0.10B |
| G&A Expenses | $0.11B | $0.10B | $0.10B | $0.08B | $0.06B |
| Total Operating Expenses | $0.55B | $0.50B | $0.49B | $0.38B | $0.28B |
| Operating Income | $0.02B | ($0.04B) | $0.03B | $0.05B | $0.07B |
| Operating Margin %(computed) | 2.10% | -5.18% | 2.46% | 6.06% | 10.88% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.03B | ($0.03B) | $0.03B | $0.05B | $0.07B |
| Income Tax Expense | $0.02B | ($0.00B) | $0.01B | $0.01B | ($0.17B) |
| Net Income | $0.02B | ($0.03B) | $0.03B | $0.04B | $0.24B |
| Net Margin %(computed) | 1.79% | -3.58% | 2.82% | 4.73% | 35.09% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.27 | $-0.45 | $0.44 | $0.63 | $3.77 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B |
| EBITDA | $0.05B | ($0.02B) | $0.04B | $0.07B | $0.09B |
| EBITDA Margin %(computed) | 5.19% | -2.82% | 4.06% | 7.71% | 12.96% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Calix, Inc.
关于Calix, Inc.(CALX)损益表
Calix, Inc.(CALX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CALX实现营收$1.00B,毛利润$0.57B(毛利率56.83%),净利润$0.02B(净利率1.79%)。
常见问题
CALX · 4 问Calix, Inc.(CALX)2025财年营收为$1.00B,同比up20.3%。
CALX revenueCALX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08